CDBT (China Dasheng Biotechnology Co) Capex-to-Revenue : 0.00 (As of Jun. 2023)

View and export this data going back to 2007. Start your Free Trial

What is China Dasheng Biotechnology Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

China Dasheng Biotechnology Co's Capital Expenditure for the six months ended in Jun. 2023 was $0.00 Mil. Its Revenue for the six months ended in Jun. 2023 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.

China Dasheng Biotechnology Co Capex-to-Revenue Historical Data

The historical data trend for China Dasheng Biotechnology Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Dasheng Biotechnology Co Capex-to-Revenue Chart

China Dasheng Biotechnology Co Annual Data

Trend

Oct06

Oct07

Jun08

Jun22

Jun23

Capex-to-Revenue

China Dasheng Biotechnology Co Semi-Annual Data
	Oct06	Oct07	Jun22	Jun23
Capex-to-Revenue	-	-	-	-

Competitive Comparison of China Dasheng Biotechnology Co's Capex-to-Revenue

For the Shell Companies subindustry, China Dasheng Biotechnology Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Dasheng Biotechnology Co's Capex-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, China Dasheng Biotechnology Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where China Dasheng Biotechnology Co's Capex-to-Revenue falls into.

Save Embed

;

Save Embed

;

China Dasheng Biotechnology Co Capex-to-Revenue Calculation

China Dasheng Biotechnology Co's Capex-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (0)	/	0
	=	N/A

China Dasheng Biotechnology Co's Capex-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (0)	/	0
	=	N/A

China Dasheng Biotechnology Co (OTCPK:CDBT) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

China Dasheng Biotechnology Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Dasheng Biotechnology Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.